{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:30:59Z","timestamp":1793313059394,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jidinnovations.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JID Innovations"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.xjidi.2026.100455","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:36:46Z","timestamp":1770079006000},"page":"100455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The tumor microenvironment of cutaneous squamous cell carcinoma in high-risk patient groups: A scoping review"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6578-7192","authenticated-orcid":false,"given":"Wandong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0034-911X","authenticated-orcid":false,"given":"Clara","family":"Harrs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2086-9363","authenticated-orcid":false,"given":"Maria C.","family":"Bolling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8559-3674","authenticated-orcid":false,"given":"Barbara","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8053-216X","authenticated-orcid":false,"given":"Gilles F.H.","family":"Diercks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5119-6451","authenticated-orcid":false,"given":"Em\u0151ke","family":"R\u00e1cz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjidi.2026.100455_bib1","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86434","article-title":"Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22","volume":"1","author":"Abikhair","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.xjidi.2026.100455_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.636544","article-title":"The tumor microenvironment in SCC: mechanisms and therapeutic opportunities","volume":"9","author":"Am\u00f4r","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.xjidi.2026.100455_bib3","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1016\/j.jid.2022.06.017","article-title":"Defining the molecular landscape of cancer-associated stroma in cutaneous squamous cell carcinoma","volume":"142","author":"Beebe","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib4","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1681\/ASN.2015030250","article-title":"CD8+ immunosenescence predicts post-transplant cutaneous squamous cell carcinoma in high-risk patients","volume":"27","author":"Bottomley","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.xjidi.2026.100455_bib5","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3390\/ijms20082009","article-title":"The role of the immune system in cutaneous squamous cell carcinoma","volume":"20","author":"Bottomley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xjidi.2026.100455_bib6","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1600-0625.2009.00901.x","article-title":"MMP-10 (Stromelysin-2) and MMP-21 in human and murine squamous cell cancer","volume":"18","author":"Boyd","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib7","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s12094-019-02073-3","article-title":"Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years\u2019 experience of a reference centre in Spain","volume":"21","author":"Castelo","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.xjidi.2026.100455_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","article-title":"Targeting TGF-\u03b2 signaling in cancer","volume":"3","author":"Colak","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xjidi.2026.100455_bib9","first-page":"393","article-title":"Cutaneous squamous cell carcinoma: from biology to therapy","author":"Corchado-Cobos","year":"2023","journal-title":"Adv Surg Med Spec"},{"key":"10.1016\/j.xjidi.2026.100455_bib10","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1097\/TP.0000000000001759","article-title":"Effector antitumor and Regulatory T cell responses influence the development of nonmelanoma skin cancer in kidney transplant patients","volume":"101","author":"Crespo","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.xjidi.2026.100455_bib11","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/DSS.0000000000004006","article-title":"The novel checkpoint target lymphocyte-activation gene 3 is highly expressed in cutaneous squamous cell carcinoma","volume":"49","author":"Dany","year":"2023","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.xjidi.2026.100455_bib12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/bjd.19421","article-title":"Heterogeneous addiction to transforming growth factor-beta signaling in recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma","volume":"184","author":"Dayal","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib13","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jaad.2024.01.040","article-title":"Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: the SCOPE\u2013ITSCC metastases study","volume":"90","author":"de Jong","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xjidi.2026.100455_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-238966","article-title":"Successful use of immunotherapy to treat advanced cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa","volume":"14","author":"Duong","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.xjidi.2026.100455_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/exd.12878","article-title":"Differential T-cell subset representation in cutaneous squamous cell carcinoma arising in immunosuppressed versus immunocompetent individuals","volume":"25","author":"Feldmeyer","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib17","first-page":"213","article-title":"Immune disregulation in cutaneous squamous cell carcinoma of patients with recessive dystrophic epidermolysis bullosa: a single pilot study","volume":"12","author":"Filoni","year":"2022","journal-title":"Life (Basel)"},{"key":"10.1016\/j.xjidi.2026.100455_bib18","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/jdv.16022","article-title":"Morphological and morphometric analysis of cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a retrospective study","volume":"34","author":"Filoni","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2026.100455_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaad.2008.09.035","article-title":"Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986\u20132006","volume":"60","author":"Fine","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2017.11.004","article-title":"Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas","volume":"66","author":"F\u00f6ll","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.xjidi.2026.100455_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41698-020-0119-9","article-title":"Decreased cytotoxic T cells and TCR clonality in organ transplant recipients with squamous cell carcinoma","volume":"4","author":"Frazzette","year":"2020","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.xjidi.2026.100455_bib22","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/jamadermatol.2023.2029","article-title":"Rates of second tumor, metastasis, and death from cutaneous squamous cell carcinoma in patients with and without transplant-associated immunosuppression","volume":"159","author":"Gjersvik","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib23","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/TP.0b013e3181f6a0a1","article-title":"Distinct immunohistochemical phenotype of nonmelanoma skin cancers between renal transplant and immunocompetent populations","volume":"90","author":"Guti\u00e9rrez-Dalmau","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.xjidi.2026.100455_bib24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/bjd.19607","article-title":"Transforming growth factor-\u03b2 messaging: #ContextMatters","volume":"184","author":"Guttmann-Gruber","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib25","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1158\/1078-0432.CCR-08-3286","article-title":"Elevated cutaneous smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients","volume":"15","author":"Harradine","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.xjidi.2026.100455_bib26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bjd.18921","article-title":"Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility","volume":"183","author":"Has","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib27","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/17401","article-title":"Cyclosporine induces cancer progression by a cell-autonomous mechanism","volume":"397","author":"Hojo","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.xjidi.2026.100455_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/bjd\/ljad335","article-title":"MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas","volume":"190","author":"Illmer","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib29","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3349\/ymj.2008.49.6.942","article-title":"Prevalence of Foxp3 positive T regulatory cells is increased during progression of cutaneous squamous tumors","volume":"49","author":"Jang","year":"2008","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.xjidi.2026.100455_bib30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4285\/kjt.22.0013","article-title":"Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates","volume":"36","author":"Kawashima","year":"2022","journal-title":"Korean J Transplant"},{"key":"10.1016\/j.xjidi.2026.100455_bib31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1159\/000508933","article-title":"Induced remission of metastatic squamous cell carcinoma with an immune checkpoint inhibitor in a patient with recessive dystrophic epidermolysis bullosa","volume":"13","author":"Khaddour","year":"2020","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.xjidi.2026.100455_bib32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2340\/00015555-2781","article-title":"Epidemiology and outcome of squamous cell carcinoma in epidermolysis bullosa in Australia and New Zealand","volume":"98","author":"Kim","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.xjidi.2026.100455_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102900","article-title":"Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1\/2 trial","volume":"77","author":"Kiritsi","year":"2024","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.xjidi.2026.100455_bib34","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2133.2010.09924.x","article-title":"Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma","volume":"163","author":"Kivisaari","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib35","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1365-2133.2008.08466.x","article-title":"Transformation-specific matrix metalloproteinases (MMP) - 7 and MMP- 13 are expressed by tumor cells in epidermolysis bullosa-associated squamous cell carcinomas","volume":"158","author":"Kivisaari","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib36","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1155\/2011\/153108","article-title":"TGF\u03b2-signaling in squamous cell carcinoma occurring in recessive dystrophic epidermolysis bullosa","volume":"34","author":"Knaup","year":"2011","journal-title":"Anal Cell Pathol (Amst)"},{"key":"10.1016\/j.xjidi.2026.100455_bib37","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.3390\/cancers15174312","article-title":"Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: real-world experience from a Canadian Comprehensive Cancer Centre","volume":"15","author":"Koch Hein","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xjidi.2026.100455_bib38","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/CJI.0b013e3181cc2615","article-title":"Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients","volume":"33","author":"Kosmidis","year":"2010","journal-title":"J Immunother"},{"key":"10.1016\/j.xjidi.2026.100455_bib39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2340\/00015555-0876","article-title":"Differences in the peritumoural inflammatory skin infiltrate between squamous cell carcinomas in organ transplant recipients and immunocompetent patients","volume":"90","author":"Krynitz","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.xjidi.2026.100455_bib40","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1600-0560.2009.01188.x","article-title":"Matrix metalloproteinase-26 is present more frequently in squamous cell carcinomas of immunosuppressed compared with immunocompetent patients","volume":"36","author":"Kuivanen","year":"2009","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.xjidi.2026.100455_bib41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/1538-7445.AM2024-279","article-title":"Abstract 279: Iatrogenic immunosuppression emplaces tacrolimus to drive squamous skin cancer progression and influence the microenvironment","volume":"84","author":"Kumah","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.xjidi.2026.100455_bib42","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/msb.2013.17","article-title":"Global remodelling of cellular microenvironment due to loss of collagen VII","volume":"9","author":"K\u00fcttner","year":"2013","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.xjidi.2026.100455_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-03347-0","article-title":"Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumor cells","volume":"9","author":"Lakins","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.xjidi.2026.100455_bib45","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/stem.2907","article-title":"Cord blood-derived stem cells suppress fibrosis and may prevent malignant progression in recessive dystrophic epidermolysis bullosa","volume":"36","author":"Liao","year":"2018","journal-title":"Stem Cells"},{"key":"10.1016\/j.xjidi.2026.100455_bib46","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/exd.14281","article-title":"Over-expression of stromal periostin correlates with poor prognosis of cutaneous squamous cell carcinomas","volume":"30","author":"Lincoln","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib47","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/01.TP.0000081399.75231.3B","article-title":"Tacrolimus enhances transforming growth factor-\u03b21 expression and promotes tumor progression","volume":"76","author":"Maluccio","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.xjidi.2026.100455_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv293","article-title":"Suppression of TGF\u03b2 and angiogenesis by Type VII collagen in cutaneous SCC","volume":"108","author":"Martins","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.xjidi.2026.100455_bib49","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1242\/jcs.042895","article-title":"Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen","volume":"122","author":"Martins","year":"2009","journal-title":"J Cell Sci"},{"key":"10.1016\/j.xjidi.2026.100455_bib44","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/jamadermatol.2021.3180","article-title":"Consensus-based recommendations on the prevention of squamous cell carcinoma in solid organ transplant recipients: A Delphi consensus statement","volume":"157","author":"Massey","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib50","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1158\/0008-5472.CAN-15-1348","article-title":"Injury-driven stiffening of the dermis expedites skin carcinoma progression","volume":"76","author":"Mittapalli","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.xjidi.2026.100455_bib51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2559.2009.03324.x","article-title":"Progression of cutaneous squamous cell carcinoma in immunosuppressed patients is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic inflammatory infiltrate","volume":"55","author":"M\u00fchleisen","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.xjidi.2026.100455_bib52","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.kint.2020.12.015","article-title":"A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant","volume":"100","author":"Murakami","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.xjidi.2026.100455_bib53","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/cancers14020305","article-title":"Complement factor D is a novel biomarker and putative therapeutic target in cutaneous squamous cell carcinoma","volume":"14","author":"Nezhad","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xjidi.2026.100455_bib54","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1158\/0008-5472.CAN-11-2996","article-title":"Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa","volume":"72","author":"Ng","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.xjidi.2026.100455_bib55","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.15252\/emmm.201505061","article-title":"Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms","volume":"7","author":"Nystr\u00f6m","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.xjidi.2026.100455_bib56","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.xjidi.2026.100455_bib57","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/cancers16020471","article-title":"Epidermolysis-bullosa-associated squamous cell carcinomas support an immunosuppressive tumor microenvironment: prospects for immunotherapy","volume":"16","author":"Rafei-Shamsabadi","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xjidi.2026.100455_bib58","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.3390\/cancers16132476","article-title":"Citrullinated histone H3, a marker for neutrophil extracellular traps, is associated with poor prognosis in cutaneous squamous cell carcinoma developing in patients with recessive dystrophic epidermolysis bullosa","volume":"16","author":"Ragot","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xjidi.2026.100455_bib59","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ajpath.2017.01.006","article-title":"Complement Component C3 and complement factor B promote growth of cutaneous squamous cell carcinoma","volume":"187","author":"Riihil\u00e4","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.xjidi.2026.100455_bib60","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/jid.2014.376","article-title":"Complement factor I promotes progression of cutaneous squamous cell carcinoma","volume":"135","author":"Riihil\u00e4","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib61","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/bjd.18095","article-title":"Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma","volume":"182","author":"Riihil\u00e4","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib62","first-page":"1927","article-title":"Conversion from calcineurin inhibitors to sirolimus reduces vascularization and thickness of post-transplant cutaneous squamous cell carcinomas","volume":"29","author":"Rival-Tringali","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.xjidi.2026.100455_bib63","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3875","article-title":"Cutaneous squamous cell carcinoma in epidermolysis bullosa: a 28-year retrospective study","volume":"101","author":"Robertson","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.xjidi.2026.100455_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1084873","article-title":"Understanding the squamous cell carcinoma immune microenvironment","volume":"14","author":"Saeidi","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.xjidi.2026.100455_bib65","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/jdv.13151","article-title":"Peritumoral dermis of squamous cell carcinomas in renal transplant recipients contains less CD11c+ myeloid dendritic cells and FoxP3+ T cells compared to immunocompetent controls","volume":"29","author":"Sandvik","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2026.100455_bib66","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/dvdy.24554","article-title":"Transforming growth factor-\u03b2, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition","volume":"247","author":"Santibanez","year":"2018","journal-title":"Dev Dyn"},{"key":"10.1016\/j.xjidi.2026.100455_bib67","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cytogfr.2017.05.008","article-title":"Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting","volume":"36","author":"Sistigu","year":"2017","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.xjidi.2026.100455_bib68","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jamadermatol.2016.5118","article-title":"Expression of programmed cell death ligand in cutaneous squamous cell carcinoma and treatment of locally advanced disease with Pembrolizumab","volume":"153","author":"Stevenson","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib69","first-page":"405","article-title":"Altered density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma of organ transplant recipients","volume":"179","author":"Strobel","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib70","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.18632\/oncotarget.14374","article-title":"Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages","volume":"8","author":"Takahashi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.xjidi.2026.100455_bib71","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.3390\/cancers13225645","article-title":"Biology and treatment advances in cutaneous squamous cell carcinoma","volume":"13","author":"Thai","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xjidi.2026.100455_bib72","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v103.4870","article-title":"Variable outcome of immunotherapy in advanced multiple cutaneous squamous cell carcinomas in two patients with recessive dystrophic epidermolysis bullosa","volume":"103","author":"Trefzer","year":"2023","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.xjidi.2026.100455_bib73","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.xjidi.2026.100455_bib74","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/onco.13539","article-title":"A pilot study of checkpoint inhibitors in solid organ transplant recipients with metastatic cutaneous squamous cell carcinoma","volume":"26","author":"Tsung","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.xjidi.2026.100455_bib75","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/exd.14304","article-title":"Role of transforming growth factor-\u03b21 in recessive dystrophic epidermolysis bullosa squamous cell carcinoma","volume":"30","author":"Twaroski","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib76","doi-asserted-by":"crossref","first-page":"F433","DOI":"10.1152\/ajprenal.00226.2022","article-title":"Tacrolimus induces fibroblast-to-myofibroblast transition via a TGF-\u03b2-dependent mechanism to contribute to renal fibrosis","volume":"324","author":"Ume","year":"2023","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.xjidi.2026.100455_bib77","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00262-018-2138-8","article-title":"PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma","volume":"67","author":"Varki","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.xjidi.2026.100455_bib78","doi-asserted-by":"crossref","first-page":"41497","DOI":"10.18632\/oncotarget.6359","article-title":"Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients","volume":"6","author":"Verneuil","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.xjidi.2026.100455_bib83","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1346-8138.1992.tb03183.x","article-title":"Langerhans cells, inflammation markers and human papillomavirus infections in benign and malignant epithelial tumors from transplant recipients","volume":"19","author":"Viac","year":"1992","journal-title":"J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100455_bib79","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41568-023-00583-5","article-title":"Advances in cutaneous squamous cell carcinoma","volume":"23","author":"Winge","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.xjidi.2026.100455_bib80","article-title":"Increased Tc22 and Treg\/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xjidi.2026.100455_bib81","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5021\/ad.22.175","article-title":"The tumor immune microenvironment in cutaneous squamous cell carcinoma arising in organ transplant recipients","volume":"35","author":"Zilberg","year":"2023","journal-title":"Ann Dermatol"}],"container-title":["JID Innovations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266702672600007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266702672600007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:12:28Z","timestamp":1779196348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266702672600007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S266702672600007X"],"URL":"https:\/\/doi.org\/10.1016\/j.xjidi.2026.100455","relation":{},"ISSN":["2667-0267"],"issn-type":[{"value":"2667-0267","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The tumor microenvironment of cutaneous squamous cell carcinoma in high-risk patient groups: A scoping review","name":"articletitle","label":"Article Title"},{"value":"JID Innovations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjidi.2026.100455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}],"article-number":"100455"}}